Ray Dalio acquired 401k Adma Biologics shares worth $4.2M. That's 0.02% of their equity portfolio (506th largest holding). Ray Dalio started to build up the position in Adma Biologics in Q3 2025 and continued to invest until Q1 2026. Since then they sold 71k shares. The investor's estimated purchase price is $6.58M, resulting in a loss of 36%.